Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
61.54
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
What Analysts Are Saying About CVS Health Stock
October 01, 2024
Via
Benzinga
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
October 01, 2024
CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017.
Via
Benzinga
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
September 30, 2024
U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stock Of The Day: Is It Time To Sell CVS?
September 30, 2024
The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms.
Via
Benzinga
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
September 30, 2024
CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit.
Via
Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
September 24, 2024
Via
Benzinga
Spotlight on CVS Health: Analyzing the Surge in Options Activity
September 23, 2024
Via
Benzinga
Is CVS Health Stock a Buy?
September 22, 2024
It's been a year to forget for the healthcare company.
Via
The Motley Fool
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
September 25, 2024
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations.
Via
MarketBeat
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
September 24, 2024
The FTC is going after these PBMs. Is this an opportunity for investors?
Via
The Motley Fool
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
September 20, 2024
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Behind the Scenes of CVS Health's Latest Options Trends
September 11, 2024
Via
Benzinga
What 9 Analyst Ratings Have To Say About CVS Health
September 10, 2024
Via
Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
September 20, 2024
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
September 20, 2024
Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical...
Via
Benzinga
Topics
Fraud
Exposures
Legal
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 20, 2024
Via
Benzinga
CVS Subsidiary Oak Street Health Agrees to $60M Settlement in Medicare Kickback Violations
September 19, 2024
Oak Street Health has agreed to pay $60 million to settle claims that it violated the False Claims Act by providing kickbacks to agents for recruiting seniors to its Medicare Advantage clinics,...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
CVS Health's Options: A Look at What the Big Money is Thinking
September 09, 2024
Via
Benzinga
4 Dividend Stocks to Double Up On Right Now
September 18, 2024
Dividend investing is a powerful way to build wealth and financial security.
Via
The Motley Fool
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 16, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims
September 16, 2024
Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addresses fraudulent activities between 2009 and 2020 and includes significant...
Via
Benzinga
Topics
Lawsuit
Whistleblower
Exposures
Financial
Legal
3 Overlooked Stocks With Strong Value and Dividend Potential
September 13, 2024
Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term.
Via
MarketBeat
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
September 12, 2024
PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution.
Via
Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.
Via
Benzinga
CVS Shares Are Trading Lower Wednesday: What You Need To Know
September 11, 2024
CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which has created a wave of uncertainty in the healthcare sector. Here's what...
Via
Benzinga
Interest Rates, Private Equity, Stocks, Football...We've Got It All
September 11, 2024
Including an interview with former NFL linebacker Brandon Copeland.
Via
The Motley Fool
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
September 10, 2024
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.
Via
Benzinga
CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm
September 10, 2024
From
The Schall Law Firm
Via
Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit With the Schall Law Firm
September 09, 2024
From
The Schall Law Firm
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.